These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 189658)

  • 1. Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.
    Barndt R; Blankenhorn DH; Crawford DW; Brooks SH
    Ann Intern Med; 1977 Feb; 86(2):139-46. PubMed ID: 189658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression and progression of femoral atherosclerosis in human beings treated for hyperlipoproteinemia.
    Nutr Rev; 1977 May; 35(5):104-7. PubMed ID: 194177
    [No Abstract]   [Full Text] [Related]  

  • 3. The rate of atherosclerosis change during treatment of hyperlipoproteinemia.
    Blankenhorn DH; Brooks SH; Selzer RH; Barndt R
    Circulation; 1978 Feb; 57(2):355-61. PubMed ID: 618626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study.
    Olsson AG; Ruhn G; Erikson U
    J Intern Med; 1990 Jun; 227(6):381-90. PubMed ID: 2351925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of asymptomatic femoral artery atheromas in hyperlipoproteinemic patients.
    Barndt R; Blankenhorn DH; Crawford DW
    Atherosclerosis; 1974; 20(2):253-62. PubMed ID: 4370281
    [No Abstract]   [Full Text] [Related]  

  • 6. Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins.
    Vermeer BJ; van Gent CM; Goslings B; Polano MK
    Br J Dermatol; 1979 Jun; 100(6):657-66. PubMed ID: 223620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.
    Duffield RG; Lewis B; Miller NE; Jamieson CW; Brunt JN; Colchester AC
    Lancet; 1983 Sep; 2(8351):639-42. PubMed ID: 6136793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat femoral arteriography in hyperlipidemic patients. A study of progression and regression of atherosclerosis.
    Erikson U; Helmius G; Hemmingsson A; Ruhn G; Olsson AG
    Acta Radiol; 1988; 29(3):303-9. PubMed ID: 2968099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R; Salel AF
    Chest; 1973 Oct; 64(4):486-90. PubMed ID: 4355275
    [No Abstract]   [Full Text] [Related]  

  • 10. On the relation between peripheral atherosclerosis and serum lipoproteins.
    Erikson U; Ericsson M; Persson R
    Ups J Med Sci; 1979; 84(1):95-104. PubMed ID: 220766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and regression of experimental atherosclerosis.
    DePalma RG; Hubay CA; Insull W; Robinson AV; Hartman PH
    Surg Gynecol Obstet; 1970 Oct; 131(4):633-47. PubMed ID: 5458523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipidaemia and the pathogenesis of atherosclerosis.
    Walton KW
    Adv Drug Res; 1974; 9():55-67. PubMed ID: 4377199
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
    Nikkilä EA; Viikinkoski P; Valle M; Frick MH
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):220-3. PubMed ID: 6430414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dyslipoproteinemias.
    Brown DF
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple intraosseous lipomas with type-IV hyperlipoproteinemia. A case report.
    Freiberg RA; Air GW; Glueck CJ; Ishikawa T; Abrams NR
    J Bone Joint Surg Am; 1974 Dec; 56(8):1729-32. PubMed ID: 4373109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.